MA39141A1 - Anticorps anti-tau(ps422) humanisés et leurs méthodes d'utilisation - Google Patents
Anticorps anti-tau(ps422) humanisés et leurs méthodes d'utilisationInfo
- Publication number
- MA39141A1 MA39141A1 MA39141A MA39141A MA39141A1 MA 39141 A1 MA39141 A1 MA 39141A1 MA 39141 A MA39141 A MA 39141A MA 39141 A MA39141 A MA 39141A MA 39141 A1 MA39141 A1 MA 39141A1
- Authority
- MA
- Morocco
- Prior art keywords
- methods
- humanized anti
- tau antibodies
- tau
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
L'invention concerne des anticorps anti-tau(ps422) humain humanisés et des méthodes d'utilisation de ceux-ci.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13199123 | 2013-12-20 | ||
PCT/EP2014/078234 WO2015091656A1 (fr) | 2013-12-20 | 2014-12-17 | Anticorps anti-tau(ps422) humanisés et leurs méthodes d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
MA39141A1 true MA39141A1 (fr) | 2017-06-30 |
Family
ID=49876465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39141A MA39141A1 (fr) | 2013-12-20 | 2014-12-17 | Anticorps anti-tau(ps422) humanisés et leurs méthodes d'utilisation |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR098855A1 (fr) |
MA (1) | MA39141A1 (fr) |
-
2014
- 2014-12-17 MA MA39141A patent/MA39141A1/fr unknown
- 2014-12-19 AR ARP140104788A patent/AR098855A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR098855A1 (es) | 2016-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA40938A (fr) | Anticorps anti-cd79b et méthodes d'utilisation desdits anticorps | |
MA40682A (fr) | Anticorps anti-ox40 et procédés d'utilisation correspondants | |
MY191169A (en) | Anti-fcrh5 antibodies | |
MA43018B1 (fr) | Anticorps anti-pd1 et procédés d'utilisation | |
MA40576B1 (fr) | Anticorps et immunoconjugués anti-her2 | |
MA53356B1 (fr) | Formulations sous-cutanées d'anticorps anti-cd38 et leurs utilisations | |
MA39248B1 (fr) | Anticorps anti-jagged1 et procédés d'utilisation correspondants | |
MA39095A1 (fr) | Anticorps et immunoconjugués anti-cd33 | |
MA37538B1 (fr) | Anticorps et immunoconjugués anti-ly6e et procédés d'utilisation | |
UY34721A (es) | Anticuerpos anti-hla-b*27 y usos de éstos. | |
PH12014502132A1 (en) | Anti-lgr5 antibodies and immunoconjugates | |
MA40671A1 (fr) | Anticorps anti-c10orf54 et leurs utilisations | |
MA35712B1 (fr) | Anticorps anti-htra1 et leurs procédés d'utilisation | |
EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
MA35898B1 (fr) | Anticorps anti-lrp5 et leurs procédés d'utilisation | |
CR20160270A (es) | ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN | |
MX2015012326A (es) | Anticuerpos anti-crth2 y su uso. | |
CR20150247A (es) | Anticuerpos de antihemaglutinina y métodos de uso | |
MX2014014376A (es) | Anticuerpos de anti-biotina y metodos de uso. | |
BR112018009004A8 (pt) | conjugados anti-cd3-folato e seus usos | |
MX2014014381A (es) | Anticuerpos de anti-teofilina y metodos de uso. | |
MA39126B1 (fr) | Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci | |
MA39411A (fr) | Synthèse de l'énantiomère de la progestérone et ses intermédiaires | |
MA39355A1 (fr) | Anticorps anti-ox40 et procédés d'utilisation correspondants | |
MA39141A1 (fr) | Anticorps anti-tau(ps422) humanisés et leurs méthodes d'utilisation |